| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |